Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 6Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 3Multiple Myeloma 3Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Mouth Neoplasms 2Head and Neck Neoplasms 2Weight Loss 1Urinary Bladder Neoplasms 1Tobacco Use Cessation 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Splenomegaly 1Smoking Cessation 1Neoplasm Metastasis 1Meningioma 1Lymphocytosis 1Lymphadenopathy 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Gynecologic Oncology Patient 1Gastrointestinal Neoplasms 1Fever 1Fatigue 1Fallopian Tube Neoplasms 1Depression 1Dental Caries 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 59Gemcitabine 37Biopsy 33Specimen Handling 32Paclitaxel 30Magnetic Resonance Spectroscopy 30Nivolumab 29Cisplatin 26Carboplatin 25Irinotecan 24Cyclophosphamide 23Fluorouracil 22Bevacizumab 22Docetaxel 21Oxaliplatin 19Leucovorin 18Ipilimumab 17Cetuximab 17Capecitabine 17130-nm albumin-bound paclitaxel 16Everolimus 15Albumin-Bound Paclitaxel 15Trastuzumab 13olaparib 12Pemetrexed 12Erlotinib Hydrochloride 12spartalizumab 11Sorafenib 11Radiosurgery 11trastuzumab deruxtecan 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasm Metastasis × Surveys and Questionnaires × Clear all
NCT02095054 2021-04-01

Regorafenib and Cetuximab in Patients With Advanced Malignancy

M.D. Anderson Cancer Center

Phase 1 Completed
39 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡